Verastem, Inc. (VSTM)
7.335
0.00 (0.00%)
USD |
NASDAQ |
Sep 16, 13:30
Verastem Price : 7.335 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 7.48 | 7.52 | 7.245 | 7.34 | 2.840M |
| Sep 14, 2026 | 7.36 | 7.62 | 7.25 | 7.51 | 1.515M |
| Sep 11, 2026 | 7.70 | 7.788 | 7.315 | 7.32 | 1.914M |
| Sep 10, 2026 | 7.91 | 7.91 | 7.45 | 7.62 | 2.670M |
| Sep 09, 2026 | 8.01 | 8.38 | 7.80 | 7.94 | 2.401M |
| Sep 08, 2026 | 8.20 | 8.54 | 7.89 | 8.08 | 4.366M |
| Sep 04, 2026 | 7.91 | 8.21 | 7.72 | 8.20 | 2.302M |
| Sep 03, 2026 | 8.03 | 8.14 | 7.905 | 7.98 | 2.627M |
| Sep 02, 2026 | 7.70 | 8.095 | 7.68 | 8.02 | 5.261M |
| Sep 01, 2026 | 7.19 | 7.640 | 7.13 | 7.61 | 2.080M |
| Aug 31, 2026 | 7.20 | 7.32 | 7.00 | 7.22 | 1.324M |
| Aug 28, 2026 | 7.32 | 7.38 | 7.18 | 7.22 | 1.084M |
| Aug 27, 2026 | 7.38 | 7.57 | 7.305 | 7.38 | 1.300M |
| Aug 26, 2026 | 7.08 | 7.45 | 6.91 | 7.39 | 1.682M |
| Aug 25, 2026 | 6.93 | 7.195 | 6.90 | 7.08 | 1.190M |
| Aug 24, 2026 | 6.90 | 6.955 | 6.62 | 6.86 | 1.166M |
| Aug 21, 2026 | 6.88 | 7.02 | 6.784 | 6.89 | 996115.0 |
| Aug 20, 2026 | 7.25 | 7.43 | 6.63 | 6.82 | 2.294M |
| Aug 19, 2026 | 7.65 | 7.86 | 7.20 | 7.295 | 2.372M |
| Aug 18, 2026 | 7.18 | 7.678 | 7.18 | 7.43 | 2.924M |
| Aug 17, 2026 | 6.52 | 7.195 | 6.45 | 7.18 | 2.284M |
| Aug 14, 2026 | 6.66 | 6.66 | 6.44 | 6.58 | 1.280M |
| Aug 13, 2026 | 7.06 | 7.06 | 6.64 | 6.67 | 1.857M |
| Aug 12, 2026 | 7.01 | 7.101 | 6.890 | 6.95 | 1.264M |
| Aug 11, 2026 | 6.71 | 7.179 | 6.624 | 7.05 | 2.088M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.37 |
| Dianthus Therapeutics, Inc. | 104.34 |
| Alnylam Pharmaceuticals, Inc. | 241.37 |
| Anika Therapeutics, Inc. | 21.10 |
| Savara, Inc. | 5.23 |
Price Related Metrics
| PS Ratio | 7.437 |
| Price to Book Value | 13.28 |
| Earnings Yield | -33.54% |
| Market Cap | 663.68M |